by American Academy of Ophthalmology
Join Ophthalmology’s social media editors as they interview authors and editors of the American Academy of Ophthalmology’s journal family: Ophthalmology, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science.
Language
🇺🇲
Publishing Since
2/15/2022
Email Addresses
1 available
Phone Numbers
0 available
April 10, 2025
<p class="MsoNormal">How accurate are diagnoses from ChatGPT? Can ophthalmologists distinguish between artificial intelligence and human responses? Dr. Tsui speaks with Drs. Jimmy S. Chen and David B. Granet on their Ophthalmology Science article, “<a href= "https://www.ophthalmologyscience.org/article/S2666-9145(24)00136-2/fulltext">Analysis of ChatGPT Responses to Ophthalmic Cases: Can ChatGPT Think like an Ophthalmologist?</a>”</p> <p class="MsoNormal">Analysis of ChatGPT Responses to Ophthalmic Cases: Can ChatGPT Think like an Ophthalmologist? Chen, Jimmy S. et al. Ophthalmology Science, Volume 5, Issue 1.</p> <p class="MsoNormal">Sign up for the next Ophthalmology Journal Virtual Club on April 23, 2025, at <a href= "https://store.aao.org/ophthalmology-virtual-journal-club.html">https://store.aao.org/ophthalmology-virtual-journal-club.html</a></p>
March 27, 2025
<p class="MsoNormal">Dr. Drew Carey speaks with Dr. Tongalp H. Tezel on his study comparing patients with nonarteritic ischemic optic neuropathy (NAION) with healthy non-NAION patients with crowded discs and noncrowded optic discs. From his Ophthalmology article, “<a href= "https://www.aaojournal.org/article/S0161-6420(24)00557-8/fulltext">Vitreopapillary Findings in Nonarteritic Ischemic Optic Neuropathy versus Healthy Eyes</a>.”</p> <p class="MsoNormal">Vitreopapillary Findings in Nonarteritic Ischemic Optic Neuropathy versus Healthy Eyes. Hondur, Ahmet M. et al. Ophthalmology, Volume 132, Issue 3, 327 – 334</p> <p class="MsoNormal">CALL FOR ABSTRACTS! Now accepting paper, poster, and video submissions through April 8. Imagine presenting at AAO 2025; learn more and submit yours at <a href= "https://www.aao.org/annual-meeting/presenter/overview">aao.org/pod25</a></p>
March 13, 2025
<p class="MsoNormal">Dr. Edmund Tsui is joined by Dr. Majda Hadziahmetovic to discuss her meta-analysis and systematic review investigating the effectiveness of systemic and local treatments in slowing autoimmune retinopathy progression. From the Ophthalmology Science article, “<a href= "https://www.ophthalmologyscience.org/article/S2666-9145(24)00158-1/fulltext">Clinical Outcomes of Therapeutic Interventions for Autoimmune Retinopathy: A Meta-analysis and Systematic Review</a>.”</p> <p class="MsoNormal">Clinical Outcomes of Therapeutic Interventions for Autoimmune Retinopathy: A Meta-analysis and Systematic Review. Kapoor, Ishani et al. Ophthalmology Science, Volume 5, Issue 1.</p> <p class="MsoNormal">CALL FOR ABSTRACTS! Now accepting paper, poster, and video submissions through April 8. Imagine presenting at AAO 2025; learn more and submit yours at <a href= "https://www.aao.org/annual-meeting/presenter/overview">aao.org/pod25</a></p>
American Academy of Ophthalmology
MayoClinicOphthalmology
JAMA Network
Jonathan L. Prenner, MD
Ben Young and Andrew Pouw
Retina Today
Eyetube
Keyvan Koushan, MD, FRCSC
Eyetube
Cataract Coach with Uday Devgan MD
Drs. Akshay Thomas & Laura Kopplin.
Cataract and Refractive Surgery Today
ASCRS
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.